• Other
  • Exited

Mitobridge, Inc. (formerly known as Mitokyne, Inc.) is a biotechnology company discovering and developing novel small molecule modulators that enhance mitochondrial function. The Company is capitalizing on the latest biological findings that reveal new insights into the complex mechanisms that regulate mitochondrial activities and how mitochondrial dysfunction can be involved in various disease pathologies. In collaboration with Astellas and leading academic laboratories, Mitobridge aims to develop breakthrough therapeutics for genetic, metabolic, and muscle disorders.